Serum Vascular Endothelial Growth Factor and Fibronectin Predict Clinical Response to High-Dose Interleukin-2 Therapy

Journal of Clinical Oncology - United States
doi 10.1200/jco.2008.19.1106
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Clinical Oncology (ASCO)

Related search

Serum Vascular Endothelial Growth Factor Load and Interleukin-6 in Cancer Patients – Reply

British Journal of Cancer
Cancer ResearchOncology
2000English

Serum Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor-1 Levels in Patients With Fibromyalgia Syndrome

Archives of Rheumatology
Rheumatology
2019English

Following Chemotherapy: Serum Cytokine (Tumor Necrosis Factor, Interleukin-2, Interleukin-11), Immunoglobulin, Complement, Vascular Endothelial Growth Factor Levels, and the Systemic Symptoms Like Capillary Leak Syndrome

Biomarkers in Cancer
2019English

PO-0431 Serum Vascular Endothelial Growth Factor (Vegf) and Neonatal Encephalopathy

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
2014English

Ten Years of Anti-Vascular Endothelial Growth Factor Therapy

Nature Reviews Drug Discovery
MedicineDrug DiscoveryPharmacology
2016English

Vascular Endothelial Growth Factor

English

Vascular Endothelial Growth Factor

English

Heparin-Mediated Conformational Changes in Fibronectin Expose Vascular Endothelial Growth Factor Binding Sites

English

Serum Levels of Vascular Endothelial Growth Factor and Transforming Growth Factor-.Beta.1 in Patients With Atrial Fibrillation Undergoing Defibrillation Therapy.

Japanese Heart Journal
2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy